This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adachi, A Articles by Martin, M A Search for Related Content PubMed PubMed Citation Articles by Adachi, A Articles by Martin, M A

 Previous Article  |  Next Article 

J Virol. 1986 August; 59(2): 284-291

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

ABSTRACT

We constructed an infectious molecular clone of acquired immunodeficiency syndrome-associated retrovirus. Upon transfection, this clone directed the production of infectious virus particles in a wide variety of cells in addition to human T4 cells. The progeny, infectious virions, were synthesized in mouse, mink, monkey, and several human non-T cell lines, indicating the absence of any intracellular obstacle to viral RNA or protein production or assembly. During the course of these studies, a human colon carcinoma cell line, exquisitely sensitive to DNA transfection, was identified.

This article has been cited by other articles:

• Suzuki, K., Juelich, T., Lim, H., Ishida, T., Watanebe, T., Cooper, D. A., Rao, S., Kelleher, A. D. (2008). Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region. J. Biol. Chem. 283: 23353-23363 [Abstract] [Full Text]  
• Hombrouck, A., Van Remoortel, B., Michiels, M., Noppe, W., Christ, F., Eneroth, A., Sahlberg, B. L., Benkestock, K., Vrang, L., Johansson, N. G., Barreca, M. L., De Luca, L., Ferro, S., Chimirri, A., Debyser, Z., Witvrouw, M. (2008). Preclinical Evaluation of 1H-Benzylindole Derivatives as Novel Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors. Antimicrob. Agents Chemother. 52: 2861-2869 [Abstract] [Full Text]  
• Fujita, M., Otsuka, M., Miyoshi, M., Khamsri, B., Nomaguchi, M., Adachi, A. (2008). Vpx Is Critical for Reverse Transcription of the Human Immunodeficiency Virus Type 2 Genome in Macrophages. J. Virol. 82: 7752-7756 [Abstract] [Full Text]  
• Hombrouck, A., Voet, A., Van Remoortel, B., Desadeleer, C., De Maeyer, M., Debyser, Z., Witvrouw, M. (2008). Mutations in Human Immunodeficiency Virus Type 1 Integrase Confer Resistance to the Naphthyridine L-870,810 and Cross-Resistance to the Clinical Trial Drug GS-9137. Antimicrob. Agents Chemother. 52: 2069-2078 [Abstract] [Full Text]  
• Yang, W., Zhao, Y., Fabrycki, J., Hou, X., Nie, X., Sanchez, A., Phadke, A., Deshpande, M., Agarwal, A., Huang, M. (2008). Selection of Replicon Variants Resistant to ACH-806, a Novel Hepatitis C Virus Inhibitor with No Cross-Resistance to NS3 Protease and NS5B Polymerase Inhibitors. Antimicrob. Agents Chemother. 52: 2043-2052 [Abstract] [Full Text]  
• Vishwanathan, S. A., Hunter, E. (2008). Importance of the Membrane-Perturbing Properties of the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 gp41 to Viral Fusion. J. Virol. 82: 5118-5126 [Abstract] [Full Text]  
• Exline, C. M., Feng, Z., Stoltzfus, C. M. (2008). Negative and Positive mRNA Splicing Elements Act Competitively To Regulate Human Immunodeficiency Virus Type 1 Vif Gene Expression. J. Virol. 82: 3921-3931 [Abstract] [Full Text]  
• Ouellet, D. L., Plante, I., Landry, P., Barat, C., Janelle, M.-E., Flamand, L., Tremblay, M. J., Provost, P. (2008). Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 36: 2353-2365 [Abstract] [Full Text]  
• Garvey, E. P., Johns, B. A., Gartland, M. J., Foster, S. A., Miller, W. H., Ferris, R. G., Hazen, R. J., Underwood, M. R., Boros, E. E., Thompson, J. B., Weatherhead, J. G., Koble, C. S., Allen, S. H., Schaller, L. T., Sherrill, R. G., Yoshinaga, T., Kobayashi, M., Wakasa-Morimoto, C., Miki, S., Nakahara, K., Noshi, T., Sato, A., Fujiwara, T. (2008). The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral. Antimicrob. Agents Chemother. 52: 901-908 [Abstract] [Full Text]  
• Luttge, B. G., Shehu-Xhilaga, M., Demirov, D. G., Adamson, C. S., Soheilian, F., Nagashima, K., Stephen, A. G., Fisher, R. J., Freed, E. O. (2008). Molecular Characterization of Feline Immunodeficiency Virus Budding. J. Virol. 82: 2106-2119 [Abstract] [Full Text]  
• Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W.-S., Ono, A. (2008). Interaction between the Human Immunodeficiency Virus Type 1 Gag Matrix Domain and Phosphatidylinositol-(4,5)-Bisphosphate Is Essential for Efficient Gag Membrane Binding. J. Virol. 82: 2405-2417 [Abstract] [Full Text]  
• Jones, K. L., Sonza, S., Mak, J. (2008). Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription. Nucleic Acids Res 36: 1578-1588 [Abstract] [Full Text]  
• Mandal, D., Feng, Z., Stoltzfus, C. M. (2008). Gag-Processing Defect of Human Immunodeficiency Virus Type 1 Integrase E246 and G247 Mutants Is Caused by Activation of an Overlapping 5' Splice Site. J. Virol. 82: 1600-1604 [Abstract] [Full Text]  
• Warrilow, D., Meredith, L., Davis, A., Burrell, C., Li, P., Harrich, D. (2008). Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro. J. Virol. 82: 1425-1437 [Abstract] [Full Text]  
• Sato, K., Aoki, J., Misawa, N., Daikoku, E., Sano, K., Tanaka, Y., Koyanagi, Y. (2008). Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins. J. Virol. 82: 1021-1033 [Abstract] [Full Text]  
• Ryo, A., Tsurutani, N., Ohba, K., Kimura, R., Komano, J., Nishi, M., Soeda, H., Hattori, S., Perrem, K., Yamamoto, M., Chiba, J., Mimaya, J.-i., Yoshimura, K., Matsushita, S., Honda, M., Yoshimura, A., Sawasaki, T., Aoki, I., Morikawa, Y., Yamamoto, N. (2008). SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc. Natl. Acad. Sci. USA 105: 294-299 [Abstract] [Full Text]  
• Iwatani, Y., Chan, D. S.B., Wang, F., Maynard, K. S., Sugiura, W., Gronenborn, A. M., Rouzina, I., Williams, M. C., Musier-Forsyth, K., Levin, J. G. (2007). Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res 35: 7096-7108 [Abstract] [Full Text]  
• Miyagi, E., Opi, S., Takeuchi, H., Khan, M., Goila-Gaur, R., Kao, S., Strebel, K. (2007). Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1. J. Virol. 81: 13346-13353 [Abstract] [Full Text]  
• Chen, P., Hubner, W., Spinelli, M. A., Chen, B. K. (2007). Predominant Mode of Human Immunodeficiency Virus Transfer between T Cells Is Mediated by Sustained Env-Dependent Neutralization-Resistant Virological Synapses. J. Virol. 81: 12582-12595 [Abstract] [Full Text]  
• Hubner, W., Chen, P., Portillo, A. D., Liu, Y., Gordon, R. E., Chen, B. K. (2007). Sequence of Human Immunodeficiency Virus Type 1 (HIV-1) Gag Localization and Oligomerization Monitored with Live Confocal Imaging of a Replication-Competent, Fluorescently Tagged HIV-1. J. Virol. 81: 12596-12607 [Abstract] [Full Text]  
• Brockman, M. A., Schneidewind, A., Lahaie, M., Schmidt, A., Miura, T., DeSouza, I., Ryvkin, F., Derdeyn, C. A., Allen, S., Hunter, E., Mulenga, J., Goepfert, P. A., Walker, B. D., Allen, T. M. (2007). Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A. J. Virol. 81: 12608-12618 [Abstract] [Full Text]  
• Dandache, S., Sevigny, G., Yelle, J., Stranix, B. R., Parkin, N., Schapiro, J. M., Wainberg, M. A., Wu, J. J. (2007). In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Novel Protease Inhibitor of Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother. 51: 4036-4043 [Abstract] [Full Text]  
• Ntemgwa, M., Wainberg, M. A., Oliveira, M., Moisi, D., Lalonde, R., Micheli, V., Brenner, B. G. (2007). Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine. Antimicrob. Agents Chemother. 51: 3861-3869 [Abstract] [Full Text]  
• Poon, B., Chang, M. A., Chen, I. S. Y. (2007). Vpr Is Required for Efficient Nef Expression from Unintegrated Human Immunodeficiency Virus Type 1 DNA. J. Virol. 81: 10515-10523 [Abstract] [Full Text]  
• Thibault, S., Tardif, M. R., Barat, C., Tremblay, M. J. (2007). TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 1. J. Immunol. 179: 4357-4366 [Abstract] [Full Text]  
• Sakuma, R., Mael, A. A., Ikeda, Y. (2007). Alpha Interferon Enhances TRIM5{alpha}-Mediated Antiviral Activities in Human and Rhesus Monkey Cells. J. Virol. 81: 10201-10206 [Abstract] [Full Text]  
• Masse, S., Lu, X., Dekhtyar, T., Lu, L., Koev, G., Gao, F., Mo, H., Kempf, D., Bernstein, B., Hanna, G. J., Molla, A. (2007). In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir. Antimicrob. Agents Chemother. 51: 3075-3080 [Abstract] [Full Text]  
• Votteler, J., Studtrucker, N., Sorgel, S., Munch, J., Rucker, E., Kirchhoff, F., Schick, B., Henklein, P., Fossen, T., Bruns, K., Sharma, A., Wray, V., Schubert, U. (2007). Proline 35 of Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Regulates the Integrity of the N-Terminal Helix and the Incorporation of Vpr into Virus Particles and Supports the Replication of R5-Tropic HIV-1 in Human Lymphoid Tissue Ex Vivo. J. Virol. 81: 9572-9576 [Abstract] [Full Text]  
• Sakuragi, J.-i., Sakuragi, S., Shioda, T. (2007). Minimal Region Sufficient for Genome Dimerization in the Human Immunodeficiency Virus Type 1 Virion and Its Potential Roles in the Early Stages of Viral Replication. J. Virol. 81: 7985-7992 [Abstract] [Full Text]  
• Takeuchi, H., Buckler-White, A., Goila-Gaur, R., Miyagi, E., Khan, M. A., Opi, S., Kao, S., Sokolskaja, E., Pertel, T., Luban, J., Strebel, K. (2007). Vif Counteracts a Cyclophilin A-Imposed Inhibition of Simian Immunodeficiency Viruses in Human Cells. J. Virol. 81: 8080-8090 [Abstract] [Full Text]  
• Muckenfuss, H., Kaiser, J. K., Krebil, E., Battenberg, M., Schwer, C., Cichutek, K., Munk, C., Flory, E. (2007). Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene. Nucleic Acids Res 35: 3784-3796 [Abstract] [Full Text]  
• Hombrouck, A., Hantson, A., van Remoortel, B., Michiels, M., Vercammen, J., Rhodes, D., Tetz, V., Engelborghs, Y., Christ, F., Debyser, Z., Witvrouw, M. (2007). Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action. J Antimicrob Chemother 59: 1084-1095 [Abstract] [Full Text]  
• Kumar, P. P., Mehta, S., Purbey, P. K., Notani, D., Jayani, R. S., Purohit, H. J., Raje, D. V., Ravi, D. S., Bhonde, R. R., Mitra, D., Galande, S. (2007). SATB1-Binding Sequences and Alu-Like Motifs Define a Unique Chromatin Context in the Vicinity of Human Immunodeficiency Virus Type 1 Integration Sites. J. Virol. 81: 5617-5627 [Abstract] [Full Text]  
• Marsden, M. D., Zack, J. A. (2007). Human Immunodeficiency Virus Bearing a Disrupted Central DNA Flap Is Pathogenic In Vivo. J. Virol. 81: 6146-6150 [Abstract] [Full Text]  
• Martin, G., Roy, J., Barat, C., Ouellet, M., Gilbert, C., Tremblay, M. J. (2007). Human Immunodeficiency Virus Type 1-Associated CD40 Ligand Transactivates B Lymphocytes and Promotes Infection of CD4+ T Cells. J. Virol. 81: 5872-5881 [Abstract] [Full Text]  
• Christensen, H. S., Daher, A., Soye, K. J., Frankel, L. B., Alexander, M. R., Laine, S., Bannwarth, S., Ong, C. L., Chung, S. W. L., Campbell, S. M., Purcell, D. F. J., Gatignol, A. (2007). Small Interfering RNAs against the TAR RNA Binding Protein, TRBP, a Dicer Cofactor, Inhibit Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression and Viral Production. J. Virol. 81: 5121-5131 [Abstract] [Full Text]  
• Waheed, A. A., Ablan, S. D., Roser, J. D., Sowder, R. C., Schaffner, C. P., Chertova, E., Freed, E. O. (2007). HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease. Proc. Natl. Acad. Sci. USA 104: 8467-8471 [Abstract] [Full Text]  
• Palmer, M. T., Kirkman, R., Kosloff, B. R., Eipers, P. G., Morrow, C. D. (2007). tRNA Isoacceptor Preference prior to Retrovirus Gag-Pol Junction Links Primer Selection and Viral Translation. J. Virol. 81: 4397-4404 [Abstract] [Full Text]  
• Priceputu, E., Hanna, Z., Hu, C., Simard, M.-C., Vincent, P., Wildum, S., Schindler, M., Kirchhoff, F., Jolicoeur, P. (2007). Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice. J. Virol. 81: 4677-4693 [Abstract] [Full Text]  
• Anderson, J. L., Johnson, A. T., Howard, J. L., Purcell, D. F. J. (2007). Both Linear and Discontinuous Ribosome Scanning Are Used for Translation Initiation from Bicistronic Human Immunodeficiency Virus Type 1 env mRNAs. J. Virol. 81: 4664-4676 [Abstract] [Full Text]  
• Mangino, G., Percario, Z. A., Fiorucci, G., Vaccari, G., Manrique, S., Romeo, G., Federico, M., Geyer, M., Affabris, E. (2007). In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, I{kappa}B Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon. J. Virol. 81: 2777-2791 [Abstract] [Full Text]  
• Fakruddin, J. M., Lempicki, R. A., Gorelick, R. J., Yang, J., Adelsberger, J. W., Garcia-Pineres, A. J., Pinto, L. A., Lane, H. C., Imamichi, T. (2007). Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood 109: 1841-1849 [Abstract] [Full Text]  
• Oguariri, R. M., Brann, T. W., Imamichi, T. (2007). Hydroxyurea and Interleukin-6 Synergistically Reactivate HIV-1 Replication in a Latently Infected Promonocytic Cell Line via SP1/SP3 Transcription Factors. J. Biol. Chem. 282: 3594-3604 [Abstract] [Full Text]  
• Aguiar, R. S., Costa, L. J., Pereira, H. S., Brindeiro, R. M., Tanuri, A. (2007). Development of a New Methodology for Screening of Human Immunodeficiency Virus Type 1 Microbicides Based on Real-Time PCR Quantification. Antimicrob. Agents Chemother. 51: 638-644 [Abstract] [Full Text]  
• Whitcomb, J. M., Huang, W., Fransen, S., Limoli, K., Toma, J., Wrin, T., Chappey, C., Kiss, L. D. B., Paxinos, E. E., Petropoulos, C. J. (2007). Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism. Antimicrob. Agents Chemother. 51: 566-575 [Abstract] [Full Text]  
• Tsurutani, N., Yasuda, J., Yamamoto, N., Choi, B.-I., Kadoki, M., Iwakura, Y. (2007). Nuclear Import of the Preintegration Complex Is Blocked upon Infection by Human Immunodeficiency Virus Type 1 in Mouse Cells. J. Virol. 81: 677-688 [Abstract] [Full Text]  
• Nikolenko, G. N., Delviks-Frankenberry, K. A., Palmer, S., Maldarelli, F., Fivash, M. J. Jr., Coffin, J. M., Pathak, V. K. (2007). Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc. Natl. Acad. Sci. USA 104: 317-322 [Abstract] [Full Text]  
• Breton, M., Zhao, C., Ouellette, M., Tremblay, M. J., Papadopoulou, B. (2007). A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection. J. Gen. Virol. 88: 217-225 [Abstract] [Full Text]  
• Balzarini, J., Van Laethem, K., Daelemans, D., Hatse, S., Bugatti, A., Rusnati, M., Igarashi, Y., Oki, T., Schols, D. (2007). Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus. J. Virol. 81: 362-373 [Abstract] [Full Text]  
• Bobardt, M. D., Chatterji, U., Selvarajah, S., Van der Schueren, B., David, G., Kahn, B., Gallay, P. A. (2007). Cell-Free Human Immunodeficiency Virus Type 1 Transcytosis through Primary Genital Epithelial Cells. J. Virol. 81: 395-405 [Abstract] [Full Text]  
• Roulet, V., Satie, A.-P., Ruffault, A., Tortorec, A. L., Denis, H., Guist'hau, O., Patard, J.-J., Rioux-Leclerq, N., Gicquel, J., Jegou, B., Dejucq-Rainsford, N. (2006). Susceptibility of Human Testis to Human Immunodeficiency Virus-1 Infection in Situ and in Vitro. Am. J. Pathol. 169: 2094-2103 [Abstract] [Full Text]  
• Adamson, C. S., Ablan, S. D., Boeras, I., Goila-Gaur, R., Soheilian, F., Nagashima, K., Li, F., Salzwedel, K., Sakalian, M., Wild, C. T., Freed, E. O. (2006). In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat). J. Virol. 80: 10957-10971 [Abstract] [Full Text]  
• Kamada, K., Igarashi, T., Martin, M. A., Khamsri, B., Hatcho, K., Yamashita, T., Fujita, M., Uchiyama, T., Adachi, A. (2006). Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. USA 103: 16959-16964 [Abstract] [Full Text]  
• Goodenow, M. M., Collman, R. G. (2006). HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes. J. Leukoc. Biol. 80: 965-972 [Abstract] [Full Text]  
• Riddle, T. M., Shire, N. J., Sherman, M. S., Franco, K. F., Sheppard, H. W., Nelson, J. A. E. (2006). Sequential Turnover of Human Immunodeficiency Virus Type 1 env throughout the Course of Infection. J. Virol. 80: 10591-10599 [Abstract] [Full Text]  
• Gurney, K. B., Uittenbogaart, C. H. (2006). Human Immunodeficiency Virus Persistence and Production in T-Cell Development. CVI 13: 1237-1245 [Abstract] [Full Text]  
• Wang, X., Douglas, S. D., Peng, J.-S., Zhou, D.-J., Wan, Q., Ho, W.-Z. (2006). An in Vitro Model of Morphine Withdrawal Manifests the Enhancing Effect on Human Immunodeficiency Virus Infection of Human T Lymphocytes through the Induction of Substance P. Am. J. Pathol. 169: 1663-1670 [Abstract] [Full Text]  
• Arhel, N., Munier, S., Souque, P., Mollier, K., Charneau, P. (2006). Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type.. J. Virol. 80: 10262-10269 [Abstract] [Full Text]  
• Waheed, A. A., Ablan, S. D., Mankowski, M. K., Cummins, J. E., Ptak, R. G., Schaffner, C. P., Freed, E. O. (2006). Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester: SELECTION FOR RESISTANT VARIANTS. J. Biol. Chem. 281: 28699-28711 [Abstract] [Full Text]  
• Brandt, S., Grunwald, T., Lucke, S., Stang, A., Uberla, K. (2006). Functional replacement of the R region of simian immunodeficiency virus-based vectors by heterologous elements.. J. Gen. Virol. 87: 2297-2307 [Abstract] [Full Text]  
• Nishitsuji, H., Kohara, M., Kannagi, M., Masuda, T. (2006). Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration.. J. Virol. 80: 7658-7666 [Abstract] [Full Text]  
• Gottwein, E., Jager, S., Habermann, A., Krausslich, H.-G. (2006). Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect.. J. Virol. 80: 6267-6275 [Abstract] [Full Text]  
• Pillai, S. K., Pond, S. L. K., Liu, Y., Good, B. M., Strain, M. C., Ellis, R. J., Letendre, S., Smith, D. M., Gunthard, H. F., Grant, I., Marcotte, T. D., McCutchan, J. A., Richman, D. D., Wong, J. K. (2006). Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain 129: 1872-1883 [Abstract] [Full Text]  
• Dykes, C., Wang, J., Jin, X., Planelles, V., An, D. S., Tallo, A., Huang, Y., Wu, H., Demeter, L. M. (2006). Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.. J. Clin. Microbiol. 44: 1930-1943 [Abstract] [Full Text]  
• Kubo, M., Nishitsuji, H., Kurihara, K., Hayashi, T., Masuda, T., Kannagi, M. (2006). Suppression of human immunodeficiency virus type 1 replication by arginine deiminase of Mycoplasma arginini. J. Gen. Virol. 87: 1589-1593 [Abstract] [Full Text]  
• Brann, T. W., Dewar, R. L., Jiang, M.-K., Shah, A., Nagashima, K., Metcalf, J. A., Falloon, J., Lane, H. C., Imamichi, T. (2006). Functional Correlation between a Novel Amino Acid Insertion at Codon 19 in the Protease of Human Immunodeficiency Virus Type 1 and Polymorphism in the p1/p6 Gag Cleavage Site in Drug Resistance and Replication Fitness.. J. Virol. 80: 6136-6145 [Abstract] [Full Text]  
• Ardon, O., Zimmerman, E. S., Andersen, J. L., DeHart, J. L., Blackett, J., Planelles, V. (2006). Induction of g2 arrest and binding to cyclophilin a are independent phenotypes of human immunodeficiency virus type 1 vpr.. J. Virol. 80: 3694-3700 [Abstract] [Full Text]  
• Harila, K., Prior, I., Sjoberg, M., Salminen, A., Hinkula, J., Suomalainen, M. (2006). Vpu and tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor pr55gag.. J. Virol. 80: 3765-3772 [Abstract] [Full Text]  
• Sokolskaja, E., Berthoux, L., Luban, J. (2006). Cyclophilin A and TRIM5{alpha} Independently Regulate Human Immunodeficiency Virus Type 1 Infectivity in Human Cells. J. Virol. 80: 2855-2862 [Abstract] [Full Text]  
• Davis, M. R., Jiang, J., Zhou, J., Freed, E. O., Aiken, C. (2006). A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41. J. Virol. 80: 2405-2417 [Abstract] [Full Text]  
• Brugger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., Krausslich, H.-G. (2006). The HIV lipidome: A raft with an unusual composition. Proc. Natl. Acad. Sci. USA 103: 2641-2646 [Abstract] [Full Text]  
• Vandekerckhove, L., Christ, F., Van Maele, B., De Rijck, J., Gijsbers, R., Van den Haute, C., Witvrouw, M., Debyser, Z. (2006). Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus. J. Virol. 80: 1886-1896 [Abstract] [Full Text]  
• Cavrois, M., Neidleman, J., Kreisberg, J. F., Fenard, D., Callebaut, C., Greene, W. C. (2006). Human Immunodeficiency Virus Fusion to Dendritic Cells Declines as Cells Mature. J. Virol. 80: 1992-1999 [Abstract] [Full Text]  
• Kuwata, T., Dehghani, H., Brown, C. R., Plishka, R., Buckler-White, A., Igarashi, T., Mattapallil, J., Roederer, M., Hirsch, V. M. (2006). Infectious Molecular Clones from a Simian Immunodeficiency Virus-Infected Rapid-Progressor (RP) Macaque: Evidence of Differential Selection of RP-Specific Envelope Mutations In Vitro and In Vivo. J. Virol. 80: 1463-1475 [Abstract] [Full Text]  
• Arlen, P. A., Brooks, D. G., Gao, L. Y., Vatakis, D., Brown, H. J., Zack, J. A. (2006). Rapid Expression of Human Immunodeficiency Virus following Activation of Latently Infected Cells. J. Virol. 80: 1599-1603 [Abstract] [Full Text]  
• Okumura, A., Lu, G., Pitha-Rowe, I., Pitha, P. M. (2006). Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. USA 103: 1440-1445 [Abstract] [Full Text]  
• Gondois-Rey, F., Biancotto, A., Fernandez, M. A., Bettendroffer, L., Blazkova, J., Trejbalova, K., Pion, M., Hirsch, I. (2006). R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L- CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. J. Virol. 80: 854-865 [Abstract] [Full Text]  
• Tachiwana, H., Shimura, M., Nakai-Murakami, C., Tokunaga, K., Takizawa, Y., Sata, T., Kurumizaka, H., Ishizaka, Y. (2006). HIV-1 Vpr Induces DNA Double-Strand Breaks. Cancer Res. 66: 627-631 [Abstract] [Full Text]  
• Wirblich, C., Bhattacharya, B., Roy, P. (2006). Nonstructural Protein 3 of Bluetongue Virus Assists Virus Release by Recruiting ESCRT-I Protein Tsg101. J. Virol. 80: 460-473 [Abstract] [Full Text]  
• Fossen, T., Wray, V., Bruns, K., Rachmat, J., Henklein, P., Tessmer, U., Maczurek, A., Klinger, P., Schubert, U. (2005). Solution Structure of the Human Immunodeficiency Virus Type 1 p6 Protein. J. Biol. Chem. 280: 42515-42527 [Abstract] [Full Text]  
• Zhou, J., Huang, L., Hachey, D. L., Chen, C. H., Aiken, C. (2005). Inhibition of HIV-1 Maturation via Drug Association with the Viral Gag Protein in Immature HIV-1 Particles. J. Biol. Chem. 280: 42149-42155 [Abstract] [Full Text]  
• Kumar, M., Mitra, D. (2005). Heat Shock Protein 40 Is Necessary for Human Immunodeficiency Virus-1 Nef-mediated Enhancement of Viral Gene Expression and Replication. J. Biol. Chem. 280: 40041-40050 [Abstract] [Full Text]  
• Turville, S. G., Vermeire, K., Balzarini, J., Schols, D. (2005). Sugar-Binding Proteins Potently Inhibit Dendritic Cell Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Dendritic-Cell-Directed HIV-1 Transfer. J. Virol. 79: 13519-13527 [Abstract] [Full Text]  
• Ong, C. L., Thorpe, J. C., Gorry, P. R., Bannwarth, S., Jaworowski, A., Howard, J. L., Chung, S., Campbell, S., Christensen, H. S., Clerzius, G., Mouland, A. J., Gatignol, A., Purcell, D. F. J. (2005). Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response. J. Virol. 79: 12763-12772 [Abstract] [Full Text]  
• Mink, M., Mosier, S. M., Janumpalli, S., Davison, D., Jin, L., Melby, T., Sista, P., Erickson, J., Lambert, D., Stanfield-Oakley, S. A., Salgo, M., Cammack, N., Matthews, T., Greenberg, M. L. (2005). Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro. J. Virol. 79: 12447-12454 [Abstract] [Full Text]  
• Wapling, J., Moore, K. L., Sonza, S., Mak, J., Tachedjian, G. (2005). Mutations That Abrogate Human Immunodeficiency Virus Type 1 Reverse Transcriptase Dimerization Affect Maturation of the Reverse Transcriptase Heterodimer. J. Virol. 79: 10247-10257 [Abstract] [Full Text]  
• Madsen, J. M., Stoltzfus, C. M. (2005). An Exonic Splicing Silencer Downstream of the 3' Splice Site A2 Is Required for Efficient Human Immunodeficiency Virus Type 1 Replication. J. Virol. 79: 10478-10486 [Abstract] [Full Text]  
• Resch, W., Parkin, N., Watkins, T., Harris, J., Swanstrom, R. (2005). Evolution of Human Immunodeficiency Virus Type 1 Protease Genotypes and Phenotypes In Vivo under Selective Pressure of the Protease Inhibitor Ritonavir. J. Virol. 79: 10638-10649 [Abstract] [Full Text]  
• Nakayama, E. E., Miyoshi, H., Nagai, Y., Shioda, T. (2005). A Specific Region of 37 Amino Acid Residues in the SPRY (B30.2) Domain of African Green Monkey TRIM5{alpha} Determines Species-Specific Restriction of Simian Immunodeficiency Virus SIVmac Infection. J. Virol. 79: 8870-8877 [Abstract] [Full Text]  
• Gottwein, E., Krausslich, H.-G. (2005). Analysis of Human Immunodeficiency Virus Type 1 Gag Ubiquitination. J. Virol. 79: 9134-9144 [Abstract] [Full Text]  
• Lucke, S., Grunwald, T., Uberla, K. (2005). Reduced Mobilization of Rev-Responsive Element-Deficient Lentiviral Vectors. J. Virol. 79: 9359-9362 [Abstract] [Full Text]  
• Witvrouw, M., Fikkert, V., Hantson, A., Pannecouque, C., O'Keefe, B. R., McMahon, J., Stamatatos, L., de Clercq, E., Bolmstedt, A. (2005). Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A. J. Virol. 79: 7777-7784 [Abstract] [Full Text]  
• Miles, L. R., Agresta, B. E., Khan, M. B., Tang, S., Levin, J. G., Powell, M. D. (2005). Effect of Polypurine Tract (PPT) Mutations on Human Immunodeficiency Virus Type 1 Replication: a Virus with a Completely Randomized PPT Retains Low Infectivity. J. Virol. 79: 6859-6867 [Abstract] [Full Text]  
• Kinomoto, M., Yokoyama, M., Sato, H., Kojima, A., Kurata, T., Ikuta, K., Sata, T., Tokunaga, K. (2005). Amino Acid 36 in the Human Immunodeficiency Virus Type 1 gp41 Ectodomain Controls Fusogenic Activity: Implications for the Molecular Mechanism of Viral Escape from a Fusion Inhibitor. J. Virol. 79: 5996-6004 [Abstract] [Full Text]